Global Ophthalmic Viscoelastic Device Market Size By Type (Cohesive OVDs, Dispersive OVDs), By Application (Hospitals And Clinics, Ambulatory Care Center), By Region, And Segment Forecasts, 2023 to 20...

The Global Ophthalmic Viscoelastic Device Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.84 billion by 2031, growing at a CAGR of 6.5% during the forecast period of 2023–2031. The market is driven by the increasing prevalence of age-related eye disorders, such as cataracts and glaucoma, as well as the growing number of ophthalmic surgeries worldwide. Ophthalmic viscoelastic devices (OVDs) are widely used in procedures like cataract surgery, corneal transplantation, and glaucoma surgery to protect ocular tissues and maintain space in the anterior chamber.

Drivers:

Rising Prevalence of Cataract and Other Eye Disorders:

The global increase in aging population is leading to a higher incidence of cataracts, a primary driver for ophthalmic surgeries. This, in turn, fuels the demand for OVDs to ensure procedural efficiency and safety.

Technological Advancements in OVD Formulations:

Innovations in viscoelastic material composition, including dispersive and cohesive variants, offer enhanced surgical outcomes. The development of combination OVDs (dual viscoelastics) is a significant trend supporting market expansion.

Growth in Ophthalmic Surgical Procedures:

Increased access to eye care, expansion of outpatient surgery centers, and the rising demand for refractive surgeries have all contributed to the growing use of OVDs.

Restraints:

High Cost of Advanced OVDs:

Premium OVDs with specialized formulations tend to be expensive, which can restrict their adoption in cost-sensitive regions or public healthcare systems.

Risk of Postoperative Complications:

Improper use or incomplete removal of OVDs can result in complications such as intraocular pressure spikes, limiting adoption among surgeons concerned about patient safety.

Opportunity:

Expansion in Emerging Markets:

Regions such as Asia-Pacific and Latin America are seeing rising investments in healthcare infrastructure, which is creating new growth avenues for ophthalmic surgical devices, including OVDs.

Increase in Minimally Invasive Eye Surgeries:

The global trend toward minimally invasive surgical techniques has increased demand for safe and effective viscoelastic agents that aid in enhancing surgical precision and outcomes.

Market by System Type Insights:

The Cohesive Ophthalmic Viscoelastic Devices segment held the largest market share in 2023 due to its wide usage in cataract surgeries for maintaining anterior chamber depth. However, the Dispersive OVDs segment is anticipated to grow at a higher CAGR during the forecast period as these offer better corneal endothelium protection during phacoemulsification.

Market by End-Use Insights:

Hospitals and Clinics were the dominant end-user segment in 2023, accounting for over 60% of the market share, attributed to the high volume of ophthalmic procedures performed in these settings. Meanwhile, Ambulatory Surgical Centers (ASCs) are expected to experience rapid growth due to their cost-effectiveness and shorter patient turnover times.

Market by Regional Insights:

North America dominated the global market in 2023, driven by the high prevalence of eye disorders, favorable reimbursement policies, and advanced healthcare infrastructure. Asia-Pacific is expected to register the fastest growth, supported by increasing healthcare awareness, improving access to eye care services, and a growing elderly population in countries like China and India.

Competitive Scenario:

Key players in the global ophthalmic viscoelastic device market include:

Johnson & Johnson Vision Care

Alcon Inc.

Carl Zeiss Meditec AG

Bausch + Lomb

Rayner

Bohus BioTech AB

CIMA Technology Inc.

Aurolab

Hylenex

Precision Lens

These companies are focusing on R&D, product launches, and strategic partnerships to strengthen their market position. For instance:

In 2023, Alcon Inc. introduced a new generation of dual OVDs for enhanced efficiency in cataract surgeries.

Johnson & Johnson Vision Care expanded its product portfolio in 2024 by launching an innovative cohesive OVD suitable for premium intraocular lens (IOL) implantation.

Scope of Work – Global Ophthalmic Viscoelastic Device Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 1.84 billion

CAGR (2023–2031) 6.5%

Key Segments By System Type (Cohesive, Dispersive), By End-Use (Hospitals & Clinics, ASCs), By Region

Growth Drivers Increasing cataract surgeries, aging population, ophthalmic surgical advancements

Opportunities Expansion in emerging markets, demand for advanced OVD formulations

Key Market Developments:

2023: Alcon launched its advanced dual viscoelastic solution targeting complex cataract procedures in aging populations.